RSS-Feed abonnieren
DOI: 10.1055/s-2006-926232
The Preparation of 2-Isoxazolines from O-Propargylic Hydroxylamines via a Tandem Rearrangement-Cyclisation Reaction
Publikationsverlauf
Publikationsdatum:
06. Februar 2006 (online)
![](https://www.thieme-connect.de/media/synlett/200603/lookinside/thumbnails/10.1055-s-2006-926232-1.jpg)
Abstract
A method for the conversion of O-propargylic hydroxylamines into 2-isoxazolines in 60-84% yield is described. For 3-alkylpropargyl or 3-arylpropargyl hydroxylamines this was achieved by heating a methanolic solution of the hydrochloride salt in the presence of K2CO3. In the case of the 3-unsubstituted compounds, the hydrochloride salts were first converted to the free bases, which rearranged upon heating in methanol. In one case, the methodology was extended to enable the direct transformation of a O-propargyl phthalimide into a 2-isoxazoline in 65% yield by treatment with methyl hydrazine at room temperature over 19 hours.
Key words
isoxazoline synthesis - O-propargylic hydroxylamine - sigmatropic rearrangement
- 1
Antczak C.Bauvois B.Monneret C.Florent J.-C. Bioorg. Med. Chem. 2001, 9: 2843 - 2
Olson RE.Sielecki TM.Wityak J.Pinto DJ.Balt DG.Frietze WE.Liu J.Tobin AE.Orwat MJ.Di Meo SV.Houghton GC.Lalka GK.Mousa SA.Racanelli AL.Hausner EA.Kapil RP.Rabel SR.Thoolen MJ.Reilly TM.Anderson PS.Wexler RR. J. Med. Chem. 1999, 42: 1178 -
3a
Lang SA.Lin Y.-I. Comprehensive Heterocyclic Chemistry Vol. 6:Katritzky AR.Rees CW. Pergamon Press; Oxford: 1984. p.1-130 -
3b
Sutharchanadevi M.Muragan R. Comprehensive Heterocyclic Chemistry II Vol. 3:Katritzky AR.Rees CW.Scriven EFV. Pergamon Press; Oxford: 1996. p.221-260 -
3c
Cicchi S.Cordero FM.Giomi D. Prog. Heterocycl. Chem. 2003, 15: 261 -
4a
Huisgen R.Christl M. Chem. Ber. 1973, 106: 3291 -
4b
Padwa A. Comprehensive Organic Synthesis Vol. 4:Trost BM.Fleming I. Pergamon Press; Oxford: 1991. p.1069-1168 - For examples of recent synthetic applications see:
-
5a
Faita G.Mella M.Mortoni A.Paio A.Quadrelli P.Seneci P. Eur. J. Org. Chem. 2002, 1175 -
5b
Tsuji M.Inomata K. Chem. Lett. 2002, 1112 -
5c
Fader LD.Carreira EM. Org. Lett. 2004, 6: 2485 -
5d
Xu W.-M.Wang Y.-G.Miao M.-Z.Huang X. Synthesis 2005, 2143 -
5e
Fedou NM.Parsons PJ.Viseux EME.Whittle AJ. Org. Lett. 2005, 7: 3179 ; and references therein -
6a
Albini F.Vitali D.Oberti R.Caramella P. J. Chem. Res., Synop. 1980, 348 -
6b
Curran DP.Scanga SA.Fenk CJ. J. Org. Chem. 1984, 49: 3474 -
6c
Kurth MJ.Rodriguez MJ.Olmstead MM. J. Org. Chem. 1990, 55: 283 -
6d
Baranski A.Banki G. Collect. Czech. Chem. Commun. 1991, 56: 425 -
6e
Rai KML.Hassner A. Indian J. Chem., Sect. B.: Org. Chem. Incl. Med. Chem. 1997, 36: 242 -
6f
Basel Y.Hassner A. Synthesis 1997, 309 -
6g
Maugein N.Wagner A.Mioskowski C. Tetrahedron Lett. 1997, 38: 1547 -
6h
Enders D.Haertwig A.Ransink J. Eur. J. Org. Chem. 1998, 1793 -
6i
Maiti D.Bhattacharya PK. Synlett 1998, 385 -
6j
Sampath Kumar HM.Anjaneyula S.Yadav JS. Synth. Commun. 1999, 29: 877 -
6k
Fenk CJ. Tetrahedron Lett. 1999, 40: 7955 -
6l
Pirrung MC.Tumey LN.Raetz CRH.Jackman JE.Snehalatha K.McClerren AL.Fierke CA.Gantt SL.Rusche KM. J. Med. Chem. 2002, 45: 4359 -
7a
Kim YH.Kim SH.Park DH. Tetrahedron Lett. 1993, 34: 6063 -
7b
Pearce AJ.Walter DS.Frampton CS.Gallagher T. J. Chem. Soc., Perkin Trans. 1 1998, 847 -
7c
Basappa Sadashiva MP.Mantelingu K.Nanjunda Swamy S.Rangappa KS. Bioorg. Med. Chem. 2003, 11: 4539 - 8
Rodriguez-Franco MI.Dorronsoro I.Martinez A. Synthesis 2001, 1711 -
9a
Tecle H.Lauffer DJ.Mirzadegan T.Moos WH.Moreland DW.Pavia MR.Schwarz RD.Davis RE. Life Sci. 1993, 52: 505 -
9b
Tecle H.Barrett SD.Lauffer DJ.Augelli-Szafran C.Brann MR.Callahan MJ.Caprathe BW.Davis RE.Doyle PD.Eubanks D.Lipiniski W.Mirzadegan T.Moos WH.Moreland DW.Nelson CB.Pavia MR.Raby C.Schwarz RD.Spencer CJ.Thomas AJ.Jaen JC. J. Med. Chem. 1998, 41: 2524 - 10
Benting J.Leonhardt M.Lindell SD.Tiebes T. Comb. Chem. High Throughput Screening 2005, 8: 649 - 12
Davies SG.Jones S.Sanz MA.Teixeira FC.Fox JF. J. Chem. Soc., Chem. Commun. 1998, 2235 - 13
Kumagai T.Shimizu K.Kawamura Y.Mukai T. Tetrahedron 1981, 37: 3365 - 14
Maire M. Bull. Soc. Chim. Fr. 1908, 3: 272 - 15
D’Alcontres GS. Gazz. Chim. Ital. 1952, 82: 627 - 16
Huisgen R.Christl M. Chem. Ber. 1973, 106: 3291
References and Notes
Preparation of 3-(2-Chlorophenyl)-2-isoxazoline (
11).
A mixture of the O-propargylic hydroxylamine hydrochloride salt 1 (275 mg, 1.26 mmol), K2CO3 (175 mg, 1.27 mmol) and dry MeOH (5 mL) was heated at reflux under a nitrogen atmosphere for 7.5 h. The solution was then concentrated in vacuo at 40 °C, H2O (5 mL) was added and the mixture was extracted with CH2Cl2 (3 × 10 mL). The combined organic extracts were dried with MgSO4 and concentrated in vacuo at 40 °C. The crude product was purified by flash chromatography (gradient elution; EtOAc-heptane) to give the isoxazoline 11 as an oil (169 mg, 0.93 mmol, 74%). IR: νmax = 3066 (w), 2954 (m), 2887 (m), 1584 (m), 1476 (m), 1434 (s), 1342 (s), 1037 (m), 934 (m), 880 (s), 643 (m) cm-1. 1H NMR (300 MHz, CDCl3): δ = 3.48 (2 H, t, J = 8.7 Hz, C4-H2), 4.51 (2 H, t, J = 8.7 Hz, C5-H2), 7.26-7.38 (2 H, m, Ph), 7.43 (1 H, dd, J = 0.7, 6.3 Hz, Ph), 7.64 (1 H, dd, J = 0.8, 7.9 Hz, Ph). MS (EI): m/z (%) 183 (33) [M+], 181 (100) [M+], 155 (20), 153 (79), 151 (87), 137 (65), 113 (20), 111 (53), 75 (74). Anal. Calcd for C9H8ClNO: C, 59.52; H, 4.44; N, 7.71. Found: C, 59.60; H, 4.46; N, 7.79%. Compounds 12, 13,
[13]
14, 15,
[14]
16, 17
[13]
and 18
[15]
were prepared using an analogous procedure.
Preparation of 5-Phenyl-2-isoxazoline (
19).
The O-propargylic hydroxylamine hydrochloride salt 9 (1.84 g, 10.0 mmol) was dissolved in CH2Cl2 (20 mL) and washed with sat. NaHCO3 solution (20 mL). The aqueous phase was extracted with CH2Cl2 (3 × 10 mL) and the combined extracts were dried over MgSO4 and concentrated in vacuo at 40 °C to give the free hydroxylamine (1.44 g, 9.8 mmol). A portion of this material (300 mg, 2.04 mmol) was dissolved in dry MeOH (5 mL) and heated at reflux under a nitrogen atmosphere for 8 h. The solution was then concentrated in vacuo at 40 °C and the crude product purified by flash chromatography (gradient elution; EtOAc-heptane) to give the isoxazoline 19 as an oil (188 mg, 1.28 mmol, 63%). IR and 1H NMR spectra as previously reported.
[16]
Compound 20 was prepared using an analogous procedure.
Preparation of 3-(4-Chlorophenyl)-2-isoxazoline (
13).
Methyl hydrazine (0.15 g, 3.3 mmol) was instilled into a cooled solution (0 °C) of the phthalimide (25) (1.00 g, 3.2 mmol) in CH2Cl2 (10 mL) under a nitrogen atmosphere. The mixture was stirred at r.t. for 19 h, after which time the precipitated 2-methyl-2,3-dihydrophthalazine-1,4-dione was removed by filtration and discarded. The filtrate was diluted with Et2O (50 mL), cooled to 0 °C and anhyd HCl(g) was bubbled through for approximately 5 min to give a small amount of brown precipitate which was filtered off and discarded. The filtrate was then concentrated in vacuo at 40 °C and the crude product purified by flash chromatography (gradient elution; EtOAc-heptane) to give the isoxazole 13 as a crystalline solid (380 mg, 2.1 mmol, 65%); mp 114-116 °C (lit.
[13]
116-117 °C). IR and 1H NMR spectra as previously reported.
[13]
Compounds 17-20 were isolated as racemic mixtures.